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Abstract: Healthcare-associated infections and the rise of drug-resistant bacteria pose significant
challenges to existing antibiotic therapies. Silver nanocomposites are a promising solution to
the current crisis, however their therapeutic application requires improved understanding of
underpinning structure-function relationships. A family of chemically and structurally modified
mesoporous SBA-15 silicas were synthesized as porous host matrices to tune the physicochemical
properties of silver nanoparticles. Physicochemical characterization by transmission electron
microscopy (TEM), X-ray diffraction (XRD), X-ray photoelectron spectroscopy (XPS), X-ray absorption
near-edge spectroscopy (XANES) and porosimetry demonstrate that functionalization by a titania
monolayer and the incorporation of macroporosity both increase silver nanoparticle dispersion
throughout the silica matrix, thereby promoting Ag2CO3 formation and the release of ionic silver in
simulated tissue fluid. The Ag2CO3 concentration within functionalized porous architectures is a
strong predictor for antibacterial efficacy against a broad spectrum of pathogens, including C. difficile
and methicillin-resistant Staphylococcus aureus (MRSA).
Keywords: silver; antibacterial; titania; mesoporous; macroporous; surface functionalization
1. Introduction
Healthcare-associated infections (HCAIs) impact on millions of patients annually, and hundreds
of thousands of deaths worldwide [1–4]. Current models predict that global mortality rates will
approach 10 million annual deaths as a direct result of HCAIs by 2050 [5]. Approximately one-third
of all such HCAIs are preventable [6], and while recent improvements in hygiene standards across
the medical sector have for example significantly reduced the number of HCAIs per year in the UK,
certain groups remain at very high risk of infection during hospital visits, and infection rates for some
bacteria such as Escherichia coli have even increased [7–9].
The rise of drug-resistant bacteria which are disproportionately responsible for HCAIs,
such as methicillin-resistant Staphylococcus aureus (MRSA) and extended-spectrum beta-lactamases
(ESBL)-producing Enterobacteriaceae [2], has prompted a resurgence in the search for broad-spectrum
antibiotics to tackle HCAIs. Silver is one such broad spectrum antibiotic, effective against Gram-positive
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(e.g., MRSA, B. subtilis) and Gram-negative bacteria (e.g., E. coli, P. aeruginosa) [10], and is consequently
the subject of commercial [11] and academic interest for the treatment of existing HCAIs and
drug-resistant organisms through its incorporation in surface coatings [12], nanotechnology [13–16],
and pharmaceuticals [17–19].
A major advantage of nanoparticulate silver (and silver-based solid compounds) compared with
salts or complexes is that oxidative dissolution is confined to exposed surfaces, offering a potential
route to regulate the release of biologically active (commonly held to be Ag+) [20] species permitting
the design of long lasting antimicrobial therapies [15,21–23]. Control over silver dissolution kinetics in
Ag-nanoparticle-(NP) based systems has been investigated through tuning particle size [23–26], the use
of inert coatings to retard release [26], or control of silver speciation in nanocomposite to accelerate
dissolution and hence antibacterial activity [13,14]. Silver has also shown recent promise as a promoter
of conventional antibiotic therapies [27].
Here we explore the use of high surface area and porous metal oxide frameworks to control
the dispersion and subsequent dissolution of surface silver. The impact of framework porosity and
oxide termination on silver speciation, dissolution, and antibacterical efficacy, was studied using
ordered mesoporous and hierarchical macroporous-mesoporous SBA-15 silicas [28,29], and titania
functionalized analogues. Conformal titania surface coatings, and hierarchically porous architectures
promote silver NP dissolution and activity against Gram-positive (Staphylococcus aureus) and
Gram-negative (Pseudomonas aeruginosa) bacteria.
2. Results and Discussion
2.1. Materials Synthesis and Characterisation
Three families of ordered porous frameworks were prepared using soft or hard-soft dual
templating approaches and subsequent titania functionalization (Figure 1). Mesoporous and
macroporous-mesoporous (MM) SBA-15 silicas were prepared using a Pluronic 123 (P123) surfactant
either alone or in conjunction with 400 nm colloidal polystyrene nanospheres respectively, according to
literature methods. Titania modified variants were subsequently prepared adapting the procedure of
Landau et al. [30] to preactivate surface silanols before the self-limited grafting of titanium isopropoxide
under anhydrous conditions, and calcination. Repeated grafting cycles were used to create conformal
TiO2 monolayers encapsulating the silica supports. Silver nanoparticles were introduced to either
the parent SBA-15, or TiO2-grafted SBA-15 and TiO2-grafted MM-SBA-15, frameworks by wet
impregnation with varying silver nitrate concentrations.
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Figure 1. Synthesis of Ag-doped mesoporous silica and titania-functionalized mesoporous and
mesoporous-macroporous silica materials.
Antibiotics 2018, 7, 55 3 of 13
Textural properties of the parent SBA-15 and MM-SBA-15 supports, before and after titania
functionalization, were first characterized by transmission electronic microscopy (TEM), N2
porosimetry, X-ray diffraction (XRD), and X-ray photoelectron spectroscopy (XPS). The expected
hexagonally close-packed channels of the SBA-15 mesopore network were observed in all cases,
with surface areas and mesopore diameters decreasing with successive TiO2 grafting cycle (Figure 2 and
Figure S1), reflecting pore narrowing and partial blockage of micropores in the silica framework [31].
Uniform mesopores of 6.3 nm diameter were in accordance with previous reports [29]. No titania
crystallites were visible by TEM following grafting, indicating the formation of highly dispersed phase.
Assuming a TiO2 monolayer thickness of 0.355 nm [32], mesopore shrinkage across three grafting
cycles from 6.3 to 5.3 nm for SBA-15 was consistent with deposition of a 1.4 monolayer (ML) titania
coating, and from 6 to 5.2 nm for MM-SBA-15 consistent with 1.1 ML titania.
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Figure 2. Bright-field transmission electron microscopy (TEM) images of (a) TiO2/SBA-15 (3rd cycle
grafting), and (b) TiO2/MM-SBA-15 (3rd cycle grafting) highlighting ordered hexagonally close-packed
mesopores and uniform macropores, and the evolution of textural properties and calculated TiO2
monolayer thickness as a function of grafting cycle for (c) TiO2/SBA-15 and (d) TiO2/MM-SBA-15.
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Low-angle X-ray diffraction (XRD) (Figure 3) confirmed that titania-functionalized frameworks
retained the P6mm symmetry of the parent SBA-15 mesopore network. Wide angle XRD (Figure S2)
showed no evidence for crystalline titania phases, consistent with TEM and the formation of conformal
monolayers over the SBA-15 template. The surface chemical environment of Ti atoms within the
monolayer coatings was examined by XPS, which reveals the presence of Ti-O-Si (associated with the
silica-titania interface) and Ti-O-Ti species over both SBA-15 and MM-SBA-15 with Ti 2p5/2 binding
energies of 459.9 eV and 458.5 eV respectively. The shift to higher binding energy for Ti coordinated
to Si (through a bridging oxygen) reflects the higher electronegativity of the latter, and hence higher
induced initial charge on the former. We attribute the small shift between the Ti-O-Ti environments in
P25 and the titania monolayers to quantum size (initial and/or final state) effects.
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Figure 3. (a) Low angle X-ray diffraction (XRD), and (b) fitted Ti 2p XP spectra of TiO2/SBA-15 and
TiO2/MM-SBA-15, alongside pure silica (SBA-15) and titania (P25) references.
Silver was subsequently deposited over the unfunctionalized SBA-15, and TiO2/SBA-15 and
TiO2/MM-SBA-15 at three different nominal loadings spanning 0.3–3 wt% (see the Supplementary
Materials (Table S1); elemental analysis revealed almost identical bulk loadings for the mesoporous
materials, but systematically lower loadings for the hierarchical material. Surface and bulk silver
loadings were generally in good agreement for all materials (see the Supplementary Materials Table S1),
indicating a homogenous distribution throughout the porous frameworks. Physicochemical properties
of the resulting silver species were determined by TEM, XPS, XRD, and X-ray absorption near edge
spectroscopy (XANES). Only fcc metallic silver (JCPDS no. 04-0783) reflections were observed by XRD,
which sharpened with increasing loading (see the Supplementary Materials Figure S3), indicative of
crystallite growth. Volume averaged silver NP sizes were smaller for MM-SBA-15 (3.5–6.5 nm) than
SBA-15 (4.5–8.5 nm) at comparable loadings (~0.3 wt%), evidencing higher metal dispersion over
the hierarchically porous framework, and indeed fell below the threshold of detection for the lowest
0.25 wt% Ag/TiO2/MM-SBA-15. Ag NPs were directly visualized by TEM (see the Supplementary
Materials Figures S4–S6), which revealed a relatively broad size distribution spanning 1–20 nm over
all three supports. The mean particle size increased (and size distribution narrowed) with Ag loading
(see the Supplementary Materials Figure S7), with the smallest NPs observed over the hierarchical
support in all cases, in accordance with XRD. Ag 3d XP spectra showed the existence of two distinct
chemical environments with 3d5/2 spin-orbit split component binding energies of 368.0 eV and 370.5 eV
consistent with Ag0 and possibly a surface Ag2CO3 respectively (see the Supplementary Materials
Figure S8) [33].
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Note that discrimination of silver oxides and carbonate by XPS alone is complicated due to
their similar core-level binding energies, and anomalous negative binding energy shift of the oxides
relative to the metal [14,34,35] and therefore requires careful fitting to well-defined standards (difficult
to guarantee due to the tendency of Ag2O to oxidise, and of both oxides to adsorb atmospheric
CO2 and form surface carbonates [36]), or Auger parameter analysis employing the Ag M4,5NN
Auger transition in conjunction with 3d5/2 core-level spectra [13]. Silver speciation as metal, oxide,
or carbonate was therefore examined by linear combination fitting of Ag K-edge X-ray absorption
near-edge spectroscopy (XANES, see the Supplementary Materials Figures S9–S11). In all cases, good
spectral fits could only be obtained using Ag and Ag2CO3 components. Nanoparticle growth is
accompanied by a continuous decrease in the proportion of surface and bulk silver carbonate for all
frameworks (Figure 4). This switchover from electron deficient to metallic silver with particle size
likely reflects the higher surface energy of the latter [37], which is thus favoured for larger particles.
The bulk Ag2CO3 content determined by XANES was systematically higher than that of the surface
determined by XPS, likely reflecting the distribution of particle sizes present in all materials; XPS is
expected to more sensitive to larger (more metallic) particles preferentially located on the external
surface. AgO and Ag2O could not be detected by linear combination fitting of the XANES data.
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and Ag/TiO2/M -SBA-15 as a function of Ag loading.
2.2. Materials Performance Assaying
The release rate of ionic silver (Ag+) from the preceding SBA-15 and MM-SBA-15 frameworks
in a 0.5 M NaNO3 solution at 37 ◦C was subsequently determined by ICP-MS analysis (Figure 5).
Dissolution rates normalised to the mass of silver were inversely proportional to particle size (loading)
for all frameworks, as reported for citrate stabilized silver metal nanoparticles [23] and core-shell
silver-silica nanoparticles [26] indicating that the release of ionic silver occurred by a common
mechanism, being solely dependent on the geometric surface area of the silver nanoparticles. Coating
of the mesoporous SBA-15 by a conformal titania monolayer slightly decreased the average particle size
over the bare silica framework, and hence increased the rate of silver dissolution, a phenomenon further
enhanced by the introduction of macropores. The rate constant for Ag+ dissolution was determined
as 5244 µmol·h−1·nm−1·g1Ag by fitting the data (see the Supplementary Materials Figure S12) in
accordance with the method of Zhang et al. [23] This is significantly higher than that found for
Ag@SiO2 core-shell nanoparticles (14.7 µmol·h−1·nm−1·g−1Ag) [26], while the absolute release rate
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of the 0.3 wt% Ag/TiO2/MM-SBA-15 is consistent with that previously observed for 0.05 wt% high
surface area Ag-hydroxyapatite nanoparticles [14].
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Antibacterial activity was subsequently assessed against a range of bacteria (Pseudomonas
aeruginosa, Staphylococcus aureus, Clostridium difficile, Escherichia coli, Bacillus subtilis and MRSA) by
zone plate inhibition (ZoI) (Figure 6) using simulated body fluid (SBF), in which the antimicrobial
efficacy is proportional to the size of the colony-free zone surrounding the silver functionalized porous
frameworks. None of the parent (silver-free) materials exhibited bactericidal properties. In all cases the
ZoI values normalized to the mass of silver were inversely proportional to silver loading, mirroring the
ionic silver release rates, and superior to those reported for hydroxyapatite (HA) supported Ag3PO4
composites or Ag@SiO2 core-shell nanocomposites. For example, for S. aureus Ag/TiO2/MM-SBA-15
achieved 70 mm·gAg−1 versus 40–60 mm·gAg−1 for a high area Ag-HA [14] or 23 mm·gAg−1 for 4.5 nm
Ag nanoparticles encapsulated by a 10.5 nm mesoporous silica shell) [26]. The zone size (antibacterial
performance) decreased in the sequence Ag/TiO2/MM-SBA-15 > Ag/TiO2/SBA-15 > Ag/SBA-15.
The logarithmic reduction method was also employed to obtain a more quantitative evaluation
of antibacterial activity for representative Gram-positive and Gram-negative bacteria (Staphylococcus
aureus and Pseudomonas aeruginosa respectively). Experiments were performed in the absence
of light to eliminate any possible influence from photogenerated reactive oxygen species by the
semiconducting titania coating. All three frameworks were inactive in the absence of silver (see
the Supplementary Materials Figure S13). Corresponding decimal reduction times (D-values),
i.e., the time to kill 90% of the bacteria, normalised to the mass of silver, also evidenced an inverse
relationship with silver loading for all frameworks (Figure 7) consistent with their Ag+ release rates.
(Figures S14–S15). As for the ZoI assays, antibacterial activity followed the order Ag/TiO2/MM-SBA-15
> Ag/TiO2/SBA-15 > Ag/SBA-15, i.e., titania functionalization, and the introduction of macroporosity,
both enhanced the potency of silver nanoparticles dispersed throughout an SBA-15 framework.
Ag/MM-TiO2/SBA-15 outperformed Ag/SBA-15 by ~105% against Staphylococcus aureus and
~103% against Pseudomonas aeruginosa. The present observations are consistent with previous reports
of augmented antimicrobial efficacy arising from the preferential formation of highly soluble silver
carbonate versus silver metal over γ-alumina supports [13].
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3. Conclusions
Families of silver functionalized porous frameworks based around surfactant templated SBA-15
mesoporous silica were synthesized to investigate the impact of surface chemistry and pore architecture
on antibacterial performance. Silver nanoparticles introduced by wet impregnation of AgNO3 and
subsequent thermal processing comprised mixed metal and carbonate phases, with the concentration of
silver carbonate (and dissolution rate for ionic Ag+) inversely proportional to particle size independent
of the framework. The introduction of a conformal titania monolayer coating of SBA-15 improved
the dispersion of silver nanoparticles, corresponding bulk and surface carbonate content, and hence
ionic silver release kinetics. This observation likely reflects the ability of defective reducible metal
oxides to act as nucleation centers for metals [38–40], thereby increasing the density of small
nanoparticles, and amphoteric nature of titania and ability to capture atmospheric CO2 [41] which can
subsequently react with (weakly basic) silver oxides [42,43] at the nanoparticle interface. Additional
rate enhancements for ionic silver were observed for hierarchical microporous-mesoporous SBA-15
frameworks, presumably due to their stabilization of even smaller silver nanoparticles and hence
higher carbonate concentrations. Silver release rates from the porous frameworks directly correlated
with broad spectrum antibacterial activity, with a 16–38% decrease in decimal reduction times
for Staphylococcus aureus and Pseudomonas aeruginosa observed following titania functionalization,
and a further 65–89% reduction following the introduction of macroporosity. The quantitative
structure-function relationship identified between the concentration of Ag2CO3 and antibacterial
efficacy will guide the development of future nanocomposite architectures, notably optimization of
the reducible metal oxide coatings and pore networks to further promote ionic silver release.
4. Materials and Methods
Polystyrene bead templates were synthesized using a method developed by Vaudreuil et al. [44]
in which styrene, divinyl benzene (comonomer, Sigma Aldrich, 80%) and potassium persulphate
(initiator, Sigma Aldrich, >99%) were the reagents. The reaction was performed on a large scale in
a 2-liter jacketed Radleys Reactor-Ready system at 90 ◦C. Deionized water (1.5 L) was introduced
to the reactor, along with a Leibig condenser, thermocouple, and a nitrogen line at 1.5 bar pressure.
The reactor was stirred at 300 rpm overnight to outgas the solution. Styrene (140 mL, Sigma Aldrich,
>99%) and divinylbenzene (27 mL) were washed with NaOH (0.1 M) three times in separate separating
funnels and added to the reaction vessel. Potassium persulfate (Sigma Aldrich, 0.35 g) was dissolved
in deionized water (20 mL) at 80 ◦C. After 30 min of stirring (300 rpm) in the reactor at 90 ◦C,
the potassium persulfate solution was added. After stirring for 3 h, the solid particles were recovered
as a concentrated solution and stored in a freezer overnight, then the product was allowed to warm
before being filtered, washed with ethanol and the beads dried at 80 ◦C overnight.
SBA-15 was prepared using a cooperative self-assembly method [29], in which a 2.6 wt% solution
of Pluronic P123 triblock copolymer (poly(ethylene glycol)-poly(propylene glycol)-poly(ethylene
glycol) (Sigma Aldrich), in 1.6-M HCl solution was stirred (500 rpm) at 35 ◦C. Tetraethyl orthoxysilicate
(Sigma Aldrich, 98%) was then added to the mixture, at a molar ratio of 60:1 [TEOS]:[P-123].
The mixture was aged at 80 ◦C for 24 h without stirring in a sealed container in an oven. The resultant
solid material was filtered, then washed with ethanol before drying in air at 100 ◦C overnight. Removal
of the P123 framework was performed by calcination at 500 ◦C in a muffle furnace for 6 h with a
ramp rate of 1 ◦C/min. Macropores were introduced by the addition of polystyrene beads to the SBA
synthesis (2.3.1) at a weight ratio of 5.3:1 [PS beads]:[TEOS] in the initial mixture.
The grafting of titania onto the surface of the prepared silica materials was done using a modified
procedure by Landau et al. [30] in which triethylamine is used to activate the surface silanols on
the silica and allow the reaction to proceed at lower temperatures. To ensure a uniform coating of
TiO2, the reaction must be performed under completely dry conditions, due to the facile hydrolysis
of the titania precursor, which will readily form large titania particles in the presence of water.
The synthetic procedure involves mixing titanium isopropoxide (Sigma Aldrich,) in anhydrous toluene
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(Aldrich, water content <0.002%), adding triethylamine (Sigma Aldrich, >99%) and MM-SBA-15 or
SBA-15 material whilst stirring at 85 ◦C for 6 h under nitrogen flow. The concentration of titanium
isopropoxide was 145 g/L, the molar ratio between titanium isopropoxide and SBA-15 was fixed at
3.5 and the triethylamine: SBA-15 weight ratio at 1.5 on a scale of 5 g of SBA-15/MM-SBA-15. After the
reaction, the solid was separated by filtration, washed with toluene (300 mL) and inserted in a 0.5 wt%
water-ethanol solution (500 mL) under stirring for 24 h. The resultant solid was washed with ethanol,
dried in air in an oven at 90 ◦C for 24 h, then calcined for 1 h at 250 ◦C, 1 h 400 ◦C and finally for 4 h at
500 ◦C all at 1 ◦C/min.
Ag NPs were deposited via wet impregnation using a solution of aqueous silver nitrate (99.9%,
Sigma-Aldrich). A slurry of the silver precursor and support (10 mL of 5–25 µM + 1 g support) was
stirred for 18 h at room temperature before heating to 50 ◦C. After 5 h, agitation was ceased and the
solid aged at 50 ◦C for a further 24 h to yield a dry powder. Dried samples were calcined at 500 ◦C
(ramp rate 1 ◦C/min) in static air for 3 h.
XRD patterns were recorded on either a PANalytical X’pertPro diffractometer fitted with an
X’celerator detector and Cu Kα (1.54 Å) source or a Bruker D8 Advance diffractometer fitted with
a LynxEye high-speed strip detector and Cu Kα (1.54 Å) source. Both instruments were calibrated
against either Si (PANalytical, Malvern, UK) or SiO2 (Bruker, Billerica, MA, USA) standards. Low angle
patterns were recorded for 2θ = 0.3–8◦ with a step size of 0.01◦. Wide angle patterns were recorded for
2θ = 10–80◦ with a step size of 0.02◦.
N2 adsorption isotherms were recorded using a Nova 4000 porosimeter (Quantachrome, Boynton
Beach, FL, USA), before which the samples were thoroughly degassed under vacuum at 120 ◦C for
2 h. T-plot analysis was used to calculate microporosity. Data was analyzed using NOVAWin version
11 (Quantachrome, Boynton Beach, FL, USA).
XPS analysis was recorded using a Kratos Axis Hsi X-ray photoelectron spectrometer (Kratos
Analytical Ltd., Manchester, UK) using a monochromated Al Kα (1486.6 eV) anode. Data was charge
corrected to adventitious carbon at 284.6 eV and analyzed using CASAXPS version 2.3.15. Ag 3D peaks
were fitted using a Doniach-Sunjic modified Gaussian-Lorentz peak shape and a doublet separation of
6 eV.
TEM analysis was performed using a JEOL 2100 microscope (JEOL Ltd., Tokyo, Japan) with a
LaB6 source and HT of 180 kV. Particle sizing was performed using ImageJ 1.46r software (open source).
Samples were prepared using a drop casting method in ethanol onto continuous carbon grids.
Dissolution rates were determined by stirring 10 mg of composite in 25 mL of 0.5 M NaNO3
at 37 ◦C with periodic aliquots of the analyte solution measured for silver content using an Agilent
6130B single Quad (ESI) ICP-MS (Agilent Technologies, Santa Clara, CA, USA) calibrated against
a range of silver concentrations made by serial dilution of a 1000 ppm Ag in 1% HNO3 standard
from Sigma-Aldrich.
The antibacterial performance of all materials was evaluated against Staphylococcus aureus ATCC
6538, MRSA ATCC 33591, Escherichia coli NCTC 10418, Bacillus subtilis NCTC 8236, Pseudomonas
aeruginosa ATCC 15442 and Clostridium difficile ATCC 9689, which are representative Gram-positive
and Gram-negative problematic organisms found in hospital environments. Zone of inhibition (ZoI)
tests were performed by inoculating the surface of a nutrient agar plate (Oxoid, Basingstoke, UK) with
an excess volume (3 mL) of nutrient broth which had previously been inoculated and incubated to
a cell density of ~108 colony-forming units (cfu)/mL as determined spectrophotometrically using
a Perkin-Elmer Lambda 10 UV-Vis spectrophotometer. The liquid was manipulated by agitation to
provide a confluent inoculum and the excess fluid removed to waste using a sterile pipette. Using a
sterilized boring tool, 5 mm holes were then bored into the agar, and 100 µL of a solution of 10 mg of
Ag nanocomposite in 5 mL of simulated body fluid (SBF, see the Supplementary Materials Table S2)
dispensed into the borehole using a calibrated micropipette. SBF was prepared according to a method
from Kokubo et al. [45] 750 mL of deionized water was stabilized at 37 ◦C with stirring, to this the
following ions were added: NaCl (7.996 g, Sigma Aldrich >99%), NaHCO3 (0.35 g, Sigma Aldrich
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>99%), KCl (0.224 g, Sigma Aldrich >99%), K2HPO4·3H2O (0.228 g, Sigma Aldrich >99%), MgCl2
(0.305 g, Sigma Aldrich >99%), HCl (40 mL, 1 kmol/L, Fisher scientific 37%), CaCl2 (0.278 g, Sigma
Aldrich >99%), Na2SO4 (0.071 g, Sigma Aldrich >99%) and (CH2OH)3CNH2 (6.057 g, Sigma Aldrich
99%). Finally, the pH was adjusted to 7.35 using HCl solution (1 kmol/L, Fisher scientific 37%).
Plates were then incubated at 37 ◦C overnight, photographed, and calibrated zone areas determined
using ImageJ software (open source).
Quantitative antimicrobial activity was determined by logarithmic reduction [13,14]. Here, 5 mg of
Ag nanocomposite material was added to an Eppendorf tube kept in dark conditions containing 1 mL
of either S. aureus or P. aeruginosa in a nutrient broth at concentrations of 107 cfu·mL−1. 100 µL aliquots
of the resulting suspensions were subsequently removed at 0, 60, 240 min and 24 h, and added to a
1 mL solution of Tween 20 (Fisher, 1%), sodium dodecyl sulphate (Sigma-Aldrich, 0.4%) and sodium
chloride (Sigma-Aldrich, 0.85%) in deionized water to neutralise any soluble silver species [13,14].
Each of the resulting neutralized solutions was serially diluted with phosphate buffered saline
(PBS) prior to plating onto agar and incubation at 37 ◦C for 24 h. The experiments were all run
with positive and negative controls of silver nitrate and without any nanocomposite respectively.
After incubation, the number of colonies present on the agar was counted by visual inspection,
and normalized relative to the initial colony count in the negative control at time t = 0 min to determine
the logarithmic reduction of bacteria. All experiments were performed in triplicate, with mean values
and standard deviations reported.
Supplementary Materials: The following are available online at http://www.mdpi.com/2079-6382/7/3/55/s1,
Figure S1: (left) N2 adsorption-desorption isotherms, and BJH pore size distributions for parent SBA-15,
TiO2/SBA-15 and TiO2/MM-SBA-15. Type-IV isotherms with H1 hysteresis is characteristic of mesoporous SBA-15,
Table S1: Elemental analysis of Ag/SBA-15, Ag/TiO2/SBA-15 and Ag/TiO2/MM-SBA-15, Figure S2: XRD patterns
for the three prepared support materials, SBA-15, TiO2/SBA-15 and TiO2/MM-SBA-15, Figure S3: XRD patterns for
(a) Ag/SBA-15; (b) Ag/TiO2/SBA-15; and (c) Ag/TiO2/MM-SBA-15 as a function of silver loading. All reflections
associated with fcc silver metal., Figure S4: Particle size distributions from TEM for (a) 0.3 wt%; (b) 0.95 wt% and
(c) 2.4 wt% Ag nanoparticles deposited on SBA-15, Figure S5: Particle size distributions from TEM (a) 0.3 wt%;
(b) 0.9 wt% and (c) 2.4 wt% Ag nanoparticles deposited on TiO2/SBA-15, Figure S6: Particle size distributions
from TEM (a) 0.25 wt%; (b) 0.75 wt% and (c) 1.2 wt% Ag nanoparticles deposited on TiO2/MM-SBA-15, Figure S6:
Particle size distributions from TEM (a) 0.25 wt%, (b) 0.75 wt% and (c) 1.2 wt% Ag nanoparticles deposited on
TiO2/MM-SBA-15, Figure S7: Mean particle size and standard deviation for Ag/SBA-15, Ag/TiO2/SBA-15,
and Ag/TiO2/MM-SBA-15 as a function of bulk silver loading, Figure S8: Fitted Ag 3d XP spectra of
(a) Ag/SBA-15; (b) Ag/TiO2/SBA-15; and (c) Ag/TiO2/MM-SBA-15 as a function of Ag loading. All spectra
fitted to carbonate and metal spin-orbit doublets possessing common lineshapes and fixed binding energies,
Figure S9: XANES profiles for (a) 0.3 wt%; (b) 0.95 wt% and (c) 2.4 wt% Ag/SBA-15, Figure S10: XANES profiles for
(a) 0.3 wt%; (b) 0.9 wt% and (c) 2.4 wt% Ag/TiO2/SBA-15, Figure S11: XANES profiles for (a) 0.25 wt%; (b) 0.75 wt%
and (c) 1.2 wt% Ag/TiO2/MM-SBA-15, Figure S12: Fitted dissolution kinetics for Ag/SBA-15, Ag/TiO2/SBA-15,
and Ag/TiO2/MM-SBA-15 as a function of particle size, Figure S13: Zone of Inhibition assays for Staphylococcus
aureus, MRSA, Escherichia coli, Bacillus subtilis, Pseudomonas aeruginosa and Clostridium difficile normalized
to the mass of silver for (a) Ag/SBA-15; (b) Ag/TiO2/SBA-15; and (c) Ag/TiO2/MM-SBA-15, Figure S14:
Logarithmic reductions for SBA-15, Ag/TiO2/SBA-15, and Ag/TiO2/MM-SBA-15 against (a) Staphylococcus aureus
and (b) Pseudomonas aeruginosa after 24 h incubation, Figure S15: Logarithmic reductions for (a) Ag/SBA-15;
(b) Ag/TiO2/SBA-15; and (c) Ag/TiO2/MM-SBA-15 against Staphylococcus aureus and Pseudomonas aeruginosa,
Figure S16: Logarithmic colony forming units of (a) S. aureus; and (b) P. aeruginosa as a function of time for
SBA-15, TiO2/SBA-15, and TiO2/MM-SBA-15, Table S1: Elemental analysis of Ag/SBA-15, Ag/TiO2/SBA-15 and
Ag/TiO2/MM-SBA-15, Table S2: Ion concentrations in SBF solution.
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